Veterinary Pain Management Market Report 2025

This Veterinary Pain Management report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The veterinary pain management market size has grown rapidly in recent years. It will grow from $2.11 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing pet ownership, advancements in veterinary medicine, humanization of pets, regulatory support.

The veterinary pain management market size is expected to see rapid growth in the next few years. It will grow to $3.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising geriatric pet population, globalization of veterinary care, focus on preventive healthcare, consumer education and advocacy. Major trends in the forecast period include technological integration, collaborations and partnerships, customized pain management plans, advancements in pain assessment tools, collaboration between veterinarians and behaviorists, nutraceuticals and functional foods.

The veterinary pain management market is anticipated to experience growth due to an increasing number of veterinary practitioners. These practitioners, who undergo specialized training in specific animal species and practice areas, are equipped to address the causes of pain in animals using specialized pain management methods. According to Veterinary Information Network Inc., the United States had 121,461 veterinarians in 2022, indicating a growing workforce capable of addressing pain in animals. Therefore, the rising number of veterinary practitioners is a key factor driving the demand for the veterinary pain management market.

The veterinary pain management market is also expected to benefit from the rising trend of pet ownership. As more individuals choose to keep pets, the demand for veterinary care increases to ensure the health and well-being of these animals. A larger pet population results in a heightened need for veterinary services, including pain management. Forbes reported that 78% of pet owners acquired pets during the pandemic, with young people (ages 18 to 25) being more likely to own a variety of pets beyond cats and dogs. Hence, the increasing prevalence of pet ownership is fueling the demand for the veterinary pain management market.

Technological advancements represent a significant trend in the veterinary pain management market, with major players focusing on innovative and technologically advanced solutions to maintain their market position. For instance, Merck Animal Health launched SenseHub Feedlot, a technology-enabled solution based on electronic ear tag technology. This system detects illness more quickly and reliably diagnoses diseases in cattle, allowing for early intervention to manage pain effectively.

Major companies operating in the veterinary pain management market are prioritizing product innovation, as exemplified by Zoetis Inc. 's development of Solensia. Solensia is a monoclonal antibody injection, a form of immunotherapy that mimics natural antibodies using man-made proteins. Zoetis Inc. launched Solensia in January 2022 as a pain reliever for feline osteoarthritis, aiming to enhance mobility, comfort, and overall well-being in cats. This once-monthly injection is administered in veterinary clinics, preventing osteoarthritis pain from interfering with the special bond between cats and their human companions.

In September 2022, Zoetis Inc. acquired NewMetrica, a UK-based company specializing in instruments and devices for pain management in animals. This acquisition enhances Zoetis's pain management portfolio, improves quality-of-life assessment capabilities, and expands product reach to Europe.

Major companies operating in the veterinary pain management market include CH Boehringer Sohn AG & Co. KG, Zoetis Inc., Merck & Co Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc., Dechra Pharmaceuticals PLC, Chanelle Pharmaceuticals Manufacturing Ltd., IDEXX Laboratories Inc., Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, SeQuent Scientific Limited, Eltech K-Laser srl, Virbac, Durvet Inc., Bimeda Inc., Inovet Pharma (A subsidiary of Orion Group), Zenex Animal Health India Private Ltd., AnimalCare Group PLC, Eco Animal Health Group PLC, Panagro Health & Nutrition, Prodivet pharmaceuticals S. A., Henry Schein Inc., Covetrus Inc., MWI Veterinary Supply Inc., Animal Health International Inc., Midwest Veterinary Supply Inc.

North America was the largest region in the veterinary pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Veterinary pain management refers to a practice that utilizes medications and related products to aid in healing and recovery while diagnosing and treating the underlying conditions to uphold the health quality of an animal. This approach is designed to improve the quality of life for both pets and livestock, ensuring comfort during and after surgical procedures or in the case of chronic conditions.

The main products in veterinary pain management include drugs and devices. Drugs encompass substances, excluding food, used to cure or alleviate the symptoms of an illness or other abnormal state. These products are applied to various types of animals, including companion animals and livestock, and are distributed through channels such as hospitals and clinics, as well as pharmacy channels. Veterinary pain management products find applications in addressing issues such as joint pain, postoperative pain, cancer-related pain, and various other veterinary health concerns.

The veterinary pain management market research report is one of a series of new reports that provides veterinary pain management market statistics, including veterinary pain management industry global market size, regional shares, competitors with veterinary pain management market share, detailed veterinary pain management market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary pain management industry. This veterinary pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary pain management market consists of revenues earned by entities by anesthetics, opioids, nonsteroidal anti-inflammatory drugs (NSIDs), alpha-2 agonists, and disease-modifying osteoarthritis agents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market consists of sales of laser therapy devices, electromagnetic therapy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.